Neuroendocrine tumor clinical trials allow participants to try promising new treatment options that researchers believe may be more effective than the current standard of care. Using currently available treatments as benchmarks, these important studies evaluate the effectiveness of new drugs, surgical techniques, chemotherapy or radiation therapy approaches and combinations of existing drugs. Clinical trial participants can be among the first to benefit from a breakthrough treatment before it is made available in other settings.
When neuroendocrine tumor clinical trials are recommended, patients might consider participating for several reasons:
- The treatment under evaluation may be the best option available.
- The new treatment may offer the potential of a better outcome or fewer side effects than the current standard of care.
- Clinical trial participants are monitored closely by a team of experts who continually refine treatment as necessary.
- A research study allows a participant to gain the satisfaction of knowing that he or she contributed personally to an advancement of medical science that can benefit all current and future patients with neuroendocrine tumors.
The scientists and clinicians at Moffitt Cancer Center conduct extensive neuroendocrine tumor clinical trials to explore new and better ways to treat all types of tumors. In recognition of our progress and commitment, the National Cancer Institute has designated Moffitt a Comprehensive Cancer Center, and we are the only cancer center based in Florida to have received this prestigious recognition. Every day, Moffitt continues to gain ground in the fight against cancer.
If you’d like to learn more, our clinical trial navigators can provide comprehensive and up-to-date information on relevant neuroendocrine tumor clinical trials that are currently available. Call 1-813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form online. Referrals are not required.